



Market Maker Surveillance Report. LPHI, OVTI, LAVA, HGSI, URZ, ZN, Losing Stocks With Lowest Price Friction For Thursday, Augu
Published in Stocks and Investing on Thursday, August 25th 2011 at 17:50 GMT by WOPRAI

August 25, 2011 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Thursday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Thursday there were 3921 companies with "abnormal" market making, 1789 companies with positive Friction Factors and 4558 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage loss per share Thursday and low price friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. LIFE PARTNERS HOLDINGS INC (NASDAQ:LPHI), OMNIVISION TECHNOLOGIES INC (NASDAQ:OVTI), MAGMA DESIGN AUTOMATION INC (NASDAQ:LAVA), HUMAN GENOME SCIENCES INC (NASDAQ:HGSI), URANERZ ENERGY CORPORATION (AMEX:URZ), ZION OIL & GAS INC (NASDAQ:ZN). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
Market Maker Friction Factor is shown in the chart below:
Symbol Change Percent Buy Volume Buy %% Sell Volume Sell %% Net Volume Friction LPHI $-1.450 -17.39% 388,451 41.96% 524,774 56.69% -136,323 -940 OVTI $-7.100 -27.50% 3,156,704 48.52% 3,292,343 50.61% -135,639 -191 LAVA $-0.600 -11.32% 921,377 43.12% 1,203,548 56.32% -282,171 -4,703 HGSI $-1.510 -11.39% 3,102,368 47.40% 3,429,371 52.39% -327,003 -2,166 URZ $-0.320 -14.41% 65,085 25.03% 125,987 48.44% -60,902 -1,903 ZN $-0.350 -11.78% 135,114 42.30% 184,306 57.70% -49,192 -1,405Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net dollar losses (Change) and extremely low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.
For example, the chart above shows LPHI with a dollar loss Thursday of $-1.45000 and a Friction Factor of -940 shares. That means that it only took 940 more shares of selling than buying to move LPHI lower by one penny. This means the Market Makers are allowing the stock to drop quickly (low friction). The combination of low friction and negative market direction can drive prices lower faster than normal.
LIFE PARTNERS HOLDINGS INC (NASDAQ:LPHI) - Life Partners Holdings, Inc., through its subsidiary, Life Partners, Inc., operates in the secondary market for life insurance in the United States. It facilitates life settlement transactions by identifying, examining, and purchasing the policies as agent for the purchasers. The companys financial transactions involve the purchase of life insurance policies at a discount to their face value for investment purposes. It serves institutional purchasers, which include investment funds designed to acquire and hold life settlements; and retail purchasers, such as high net worth individuals. The company was founded in 1971 and is based in Waco, Texas.
OMNIVISION TECHNOLOGIES INC (NASDAQ:OVTI) - OmniVision Technologies, Inc. designs, develops, and markets semiconductor image-sensor devices. The company offers CameraChip image sensors, which are single-chip solutions that integrate various functions, such as image capture, image processing, color processing, signal conversion, and output of a processed image or video stream for use in various consumer and commercial mass-market applications; and CameraCube imaging devices that are image sensors with integrated wafer-level optics. It also provides companion chips used to connect its image sensors to various interfaces, including the universal serial bus and other industry standard interfaces; and companion digital signal processors that perform compression in standardized still photo and digital video formats. In addition, the company designs and develops software drivers for Linux, Mac OS, and Microsoft Windows, as well as for embedded operating systems, such as Blackberry OS, Palm OS, Symbian, Windows CE, Windows Embedded, and Windows Mobile. Its products are used in mobile phones, notebooks, Webcams, digital still and video cameras, commercial and security and surveillance, and automotive and medical applications, as well as in entertainment devices. The company sells its products directly to original equipment manufacturers and value added resellers, as well as indirectly through distributors worldwide. OmniVision Technologies, Inc. was founded in 1995 and is based in Santa Clara, California.
MAGMA DESIGN AUTOMATION INC (NASDAQ:LAVA) - Magma Design Automation, Inc. provides electronic design automation software products and related services. The companys product line includes the Talus family of digital implementation products; the Titan product group for analog/mixed-signal design; the Quartz products for physical verification; FineSim products for circuit simulation; the Tekton static timing analyzer and QCP extractor; SiliconSmart for library characterization; and fab analysis products including Camelot and YieldManager. The companys software enables chip designers to reduce the time to design and produce integrated circuits used in the communications, computing, consumer electronics, networking, and semiconductor industries. Magmas customers include semiconductor companies and electronic products manufacturers in Asia, Europe, India, Japan, and the United States. Magma Design Automation, Inc. was founded in 1997 and is headquartered in San Jose, California.
HUMAN GENOME SCIENCES INC (NASDAQ:HGSI) - Human Genome Sciences, Inc. operates as a biopharmaceutical company. Its principal products in development include BENLYSTA for systemic lupus erythematosus; and raxibacumab for inhalation anthrax. The companys mid- and early-stage pipeline products comprise Mapatumumab for the treatment of non-small cell lung cancer, multiple myeloma, and hepatocellular cancer; IAP Inhibitors that are compounds, which block the activity of IAP (inhibitor of apoptosis) proteins, allowing apoptosis to proceed and causing the cancer cells to die; and CCR5 mAb, a human monoclonal antibody to the CCR5 receptor for the treatment of ulcerative colitis. Human Genome Sciences, Inc. also holds financial rights to certain products in the GlaxoSmithKline clinical development pipeline, including darapladib, a Phase III clinical trial product for the treatment of coronary heart disease and ischemic stroke; and Albiglutide for the treatment for type 2 diabetes, which is in Phase III clinical trial stage. The company has a license agreement with GlaxoSmithKline for the co-development and commercialization of BENLYSTA; and a collaboration and license agreement with Aegera Therapeutics, Inc. to develop and commercialize certain oncology molecules and related backup compounds. Human Genome Sciences, Inc. was founded in 1992 and is headquartered in Rockville, Maryland.
URANERZ ENERGY CORPORATION (AMEX:URZ) - Uranerz Energy Corporation, an exploration stage company, engages in the acquisition, exploitation, and development of uranium properties. The company principally focuses on the exploration of its properties in the Powder River Basin area of Wyoming encompassing approximately 119,312 acres, as well as owns interests in properties located in the Great Divide Basin area of Wyoming, Texas and in Saskatchewan, Canada. The company was formerly known as Carleton Ventures Corp. and changed its name to Uranerz Energy Corporation in July 2005. Uranerz Energy Corporation was founded in 1999 and is based in Casper, Wyoming.
ZION OIL & GAS INC (NASDAQ:ZN) - Zion Oil & Gas, Inc. operates as a development stage oil and gas exploration company in Israel. The company holds 2 exploration licenses, Asher-Menashe License and Joseph License, covering approximately 162,100 acres onshore in the state of Israel between Netanya in the south and Haifa in the north. It also holds interest in the Issachar-Zebulun permit area, located adjacent to the Asher-Menashe license area, covering approximately 165,000 acres. The company was founded in 2000 and is based in Dallas, Texas.
About BUYINS.NET
BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO
INVESTMENTS & TRADING
SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.
GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.
DISCLAIMER:
BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.
Contact:
BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net